Quality assurance in surgery - More than the documentation of postoperative complications

被引:0
作者
Grundmann, RT [1 ]
机构
[1] B BRAUN MELSUNGEN AG, MELSUNGEN, GERMANY
来源
ZENTRALBLATT FUR CHIRURGIE | 1996年 / 121卷 / 03期
关键词
quality assurance; postoperative complications; therapeutical guidelines; quality of life; cost/benefit calculations; FOR-CARDIOVASCULAR-SURGERY; NORTH-AMERICAN CHAPTER; VASCULAR-SURGERY; CAROTID ENDARTERECTOMY; PRACTICE GUIDELINES; COST-EFFECTIVENESS; INGUINAL-HERNIA; PLUG TECHNIQUE; JOINT COUNCIL; HERNIORRHAPHY;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
This review discusses several aspects of surgical quality assurance: 1. The surgical audit to collect data and analyze postoperative complications. 2. Quality assurance by measurement of patients' postoperative long-term outcome. 3. The elaboration of therapeutical guidelines. 4. Measurement of costs and benefit of the surgical intervention including patients' postoperative quality of life. 5. Quality assurance of clinical trials and medical publications. It is demonstrated that the regular documentation of postoperative complications and an internal data analysis improve the results, dependent on the quality of the data which is best guaranteed by a neutral observer. The late results after operation are mainly influenced by the quality of the surgeon, as prove recurrence rates after hernia repair ranging between 0 and 10% using identical operation techniques, or locoregional recurrences of 30-60% after abdominal perineal resection of the rectum. The elaboration of therapeutical guidelines may be helpful for the evaluation of the benefit of the intervention and for the prevention of unnecessary operations as has been demonstrated for the treatment of symptomatic and asymptomatic carotid artery stenoses. Qualified clinical studies performed according to the GCP rules with biometrical planning, clear cut definition of the purpose of the study and listing of inclusion and exclusion criteria are the prerequisites of substantiated therapeutical guidelines. Under increasing economic pressure not only the benefit, but also the costs of treatment are of major importance, the evaluation of the cost effectiveness ratio by measuring the cost per quality adjusted year of life saved will become essential for future therapeutical recommendations.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 65 条
  • [1] AMUNDSEN S, 1990, ACTA CHIR SCAND, V156, P323
  • [2] BAKAL CW, 1995, 20 ANN SCI M SCVIR F
  • [3] BALLINGER WF, 1993, SURGERY, V113, P250
  • [4] DRUG-THERAPY - DRUGS AND SURGERY IN THE PREVENTION OF ISCHEMIC STROKE
    BARNETT, HJM
    ELIASZIW, M
    MELDRUM, HE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 238 - 248
  • [5] THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT
    BIRKMEYER, JD
    GOODNOUGH, LT
    AUBUCHON, JP
    NOORDSIJ, PG
    LITTENBERG, B
    [J]. TRANSFUSION, 1993, 33 (07) : 544 - 551
  • [6] BRAUER U, 1991, MUNCH MED WSCHR, V133, P575
  • [7] BROOKS DC, 1994, ARCH SURG-CHICAGO, V129, P361
  • [8] RISK-ADJUSTED ANALYSIS OF SURGEON PERFORMANCE - A 1-YEAR STUDY
    COPELAND, GP
    SAGAR, P
    BRENNAN, J
    ROBERTS, G
    WARD, J
    CORNFORD, P
    MILLAR, A
    HARRIS, C
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 (03) : 408 - 411
  • [9] 5-YEAR PROSPECTIVE STUDY OF 23,649 SURGICAL WOUNDS
    CRUSE, PJE
    FOORD, R
    [J]. ARCHIVES OF SURGERY, 1973, 107 (02) : 206 - 210
  • [10] CRUSE PJE, 1980, SURG CLIN N AM, V60, P27